Climate Change Data Portal
DOI | 10.1126/science.aax5863 |
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia | |
Uckelmann H.J.; Kim S.M.; Wong E.M.; Hatton C.; Giovinazzo H.; Gadrey J.Y.; Krivtsov A.V.; Rücker F.G.; Döhner K.; McGeehan G.M.; Levine R.L.; Bullinger L.; Vassiliou G.S.; Armstrong S.A. | |
发表日期 | 2020 |
ISSN | 0036-8075 |
起始页码 | 586 |
结束页码 | 590 |
卷号 | 367期号:6477 |
英文摘要 | The initiating mutations that contribute to cancer development are sometimes present in premalignant cells. Whether therapies targeting these mutations can eradicate premalignant cells is unclear. Acute myeloid leukemia (AML) is an attractive system for investigating the effect of preventative treatment because this disease is often preceded by a premalignant state (clonal hematopoiesis or myelodysplastic syndrome). In Npm1c/Dnmt3a mutant knock-in mice, a model of AML development, leukemia is preceded by a period of extended myeloid progenitor cell proliferation and self-renewal. We found that this self-renewal can be reversed by oral administration of a small molecule (VTP-50469) that targets the MLL1-Menin chromatin complex. These preclinical results support the hypothesis that individuals at high risk of developing AML might benefit from targeted epigenetic therapy in a preventative setting. © 2020 American Association for the Advancement of Science. All rights reserved. |
关键词 | antileukemic agentmethionineunclassified drugvtp 50469biological developmentcancercelldisease treatmentmutationnumerical modeloral healthacute myeloid leukemiaanimal cellanimal experimentanimal modelantineoplastic activityArticlecell proliferationcell self-renewalchromatincontrolled studydrug targetinggenegene mutationleukemia cellmolecularly targeted therapymousemouse modelnonhumanNPM1 genepreleukemiapriority journalMus |
语种 | 英语 |
来源机构 | Science |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/133753 |
推荐引用方式 GB/T 7714 | Uckelmann H.J.,Kim S.M.,Wong E.M.,et al. Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia[J]. Science,2020,367(6477). |
APA | Uckelmann H.J..,Kim S.M..,Wong E.M..,Hatton C..,Giovinazzo H..,...&Armstrong S.A..(2020).Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia.,367(6477). |
MLA | Uckelmann H.J.,et al."Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia".367.6477(2020). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。